총 18,742건 중 1,000건 출력
, 22/100 페이지
-
211
-
158P Neoadjuvant treatment in stage III NSCLC: Comparison with NADIM 2 trial as a gold standard
-
Casas, F.;
Redondo, M.G. Antelo;
Sanchez-Lorente, D.;
Reyes, R.;
Martinez, D.;
Lucena, C.;
Vollmer, I.;
Cases, C.;
Mollá
, M.;
Boada, M.;
Roig, M. Parera;
Acosta, S. Castillo;
Muñ
oz, S.;
Centella, C. Urbano;
Guirao, A.;
Cobo, A.;
Benegas, M.;
Leon, F.;
Clavell, C.;
Segarra, N. Vinolas;
;
(Esmo open,
v.9,
2024,
pp.102913)
-
212
-
Apolipoprotein E2(Arg158----Cys) frequency in a hyperlipidemic French-Canadian population of apolipoprotein E2/2 subjects. Determination by synthetic oligonucleotide probes.
-
Weisgraber, K H;
Newhouse, Y M;
Taylor, J M;
Tuan, B;
Nestruck, A C;
Davignon, J;
Mahley, R W;
Gladstone Foundation Laboratories, University of California, San Francisco, CA 94140.;
Gladstone Foundation Laboratories, University of California, San Francisco, CA 94140.;
Gladstone Foundation Laboratories, University of California, San Francisco, CA 94140.;
Gladstone Foundation Laboratories, University of California, San Francisco, CA 94140.;
Gladstone Foundation Laboratories, University of California, San Francisco, CA 94140.;
Gladstone Foundation Laboratories, University of California, San Francisco, CA 94140.;
Gladstone Foundation Laboratories, University of California, San Francisco, CA 94140.;
(Arteriosclerosis : an official journal of the American Heart Association, Inc,
v.9,
1989,
pp.50-57)
-
213
-
Efficacy of pembrolizumab in phase 2 KEYNOTE-164 and KEYNOTE-158 studies of microsatellite instability high cancers
-
Diaz, L.;
Marabelle, A.;
Kim, T.W.;
Geva, R.;
Van Cutsem, E.;
André
, T.;
Ascierto, P.A.;
Maio, M.;
Delord, J-P.;
Gottfried, M.;
Guimbaud, R.;
Jaeger, D.;
Elez, E.;
Yoshino, T.;
Joe, A.;
Lam, B.;
Ding, J.;
Pruitt, S.;
Kang, S.P.;
Le, D.T.;
;
(Annals of oncology : official journal of the European Society for Medical Oncology,
v.28,
2017,
pp.v128-v129)
-
214
-
Effects Of Kinesiology Tape On Proprioception: 1505 Board #158 June 2, 8: 00 AM - 9: 30 AM
-
Jimoh, Jolaolu M.;
Zhang, Qinglai;
Patterson, Jeremy A.;
Bomgardner, Rich;
Rogers, Nicole L.;
Rogers, Michael E.;
1Wichita State University, Wichita, KS. 2Shandong University of Technology, Zibo City, China. (Sponsor: Michael E. Rogers, FACSM);
(Medicine and science in sports and exercise,
v.48,
2016,
pp.408-408)
-
215
-
P.1.158 SSRIs increase 5-HT<sub>2A</sub> receptor binding in depressed patients: A SPECT study
-
D'haenen, H.;
Schins, A.;
;
(European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
v.13,
2003,
pp.S241-S241)
-
216
-
An Energy Balance and COPE Intervention for Division I Female Athletes : 1872 Board #158 May 29, 2
-
Buffington, Brenda C.;
Zupan, Michael F.;
Melnyk, Bernadette Mazurek;
Morales, Shelly;
Lords, Amanda;
Nunley, Stan;
;
(Medicine and science in sports and exercise,
v.46,
2014,
pp.506)
-
217
-
(158〜159)銅に依るゴムの劣化を防止する方法(第1〜2報)
-
;
;
(工業化學雜誌 = Journal of the Chemical Society of Japan, industrial chemistry section,
v.43,
1940,
pp.547-551)
-
218
-
Evaluation of pembrolizumab monotherapy in patients with salivary gland carcinoma in the phase 2 KEYNOTE-158 study
-
Even, Caroline;
Delord, Jean-Pierre;
Price, Katharine A.;
Nakagawa, Kazuhiko;
Oh, Do-Youn;
Burge, Matthew;
Chung, Hyun Cheol;
Doi, Toshihiko;
Fakih, Marwan;
Takahashi, Shunji;
Xu, Lei;
Jin, Fan;
Norwood, Kevin;
Hansen, Aaron;
Gustave Roussy, INSERM U1015;
Institut Claudius Regaud IUCT-Oncopole;
Mayo Clinic;
Kindai University Hospital;
Seoul National University College of Medicine;
Royal Brisbane and Women's Hospital;
Yonsei University College of Medicine;
National Cancer Center Hospital East;
City of Hope National Medical Center;
Cancer Institute Hospital, Japanese Foundation for Cancer Research;
Merck & Co., Inc.;
Merck & Co., Inc.;
Merck & Co., Inc.;
Princess Margaret Cancer Centre;
(Oral oncology,
v.118,
2021,
pp.9-9)
-
219
-
P.2.158 Rivastigmine for the treatment of cognitive impairment in residual schizophrenia: A 6-month follow-up
-
Lenzi, A.;
Maltinti, E.;
Tiano, L.;
Manca, E.;
Spagna, F.;
Coli, E.;
;
(European College of Neuropsychopharmacology,
v.2002,
2002,
pp.S321)
-
220
-
Highly durable low CoO mass production version of 2-kHz ArF excimer laser for DUV lithography [4000-158]
-
Enami, T.;
Wakabayashi, O.;
Ishii, K.;
Terashima, K.;
Itakura, Y.;
Watanabe, T.;
Ohta, T.;
Ohbu, A.;
Kubo, H.;
Tanaka, H.;
;
(Optical microlithography,
v.2000,
2000,
pp.1435-1444)